Showing results (81-90 of 127) with videos related to

Sort By:
Pageof 13
Pharmaceutical Science Advances|January 19, 2026
Comprehensive multi-omics analysis of CD36 in pan-cancers: Evaluating role in prognosis, immune microenvironment, and therapeutic responseMuhammad Sameer Ashaq, Shengsong Wang, Meiqi Guo, et al.
Pharmaceutical Science Advances|January 19, 2026
Single-walled carbon nanotubes sensors: Preparation and bio-application advancesXiaotong Chen, Difan Wang, Wenshuo Ding, et al.
Pharmaceutical Science Advances|January 19, 2026
Blockage of HSP90 and IDO1 pathway by α-MSH modified nanoelicitor to dual-facilitate mild photothermal therapyShunli Fu, Qingping Ma, Jiangnan Li, et al.
Pharmaceutical Science Advances|June 30, 2026
Recent advances in HER2-targeted inhibitors for cancer therapyWenjian Zhu, Xiaoyun Lu
Pharmaceutical Science Advances|July 2, 2026
Calcium overload-induced apoptosis in cancer cells: ER-mitochondria crosstalk and therapeutic implicationsYucui Ding, Xinyu Liu, Jianyue Xue, et al.
Pharmaceutical Science Advances|July 13, 2026
Co-assembly of dipeptide and hydrophobic drug in hyaluronic acid through Schiff base reaction for the treatment of osteoarthritisGuixin Chen, Qin Li, Chen Yu, et al.
Pharmaceutical Science Advances|August 30, 2026
Corrigendum to "Mechanisms of tumor cell evasion from NK cell-mediated killing and advances in NK cell-based cancer immunotherapy" [Pharm. Sci. Adv. 4 (2026) 100109]Rulin Zheng, Zhuqing Wang, Baodi Zhang, et al.
Pharmaceutical Science Advances|August 30, 2026
Corrigendum to "Metabolomic profiling of Musanga cecropioides leaf extract reveals cytotoxic mechanisms in MCF-7 breast cancer cells" [Pharm. Sci. Adv. 4 (2026) 100107]Olubusola O Olaleye, Dong-Hyun Kim, Keith A Spriggs
Pharmaceutical Science Advances|September 20, 2026
Corrigendum to "Computational screening of Sophora flavescens phytochemicals as potential aromatase inhibitors: Molecular docking, ADMET, Network pharmacology, Molecular dynamics simulation, and DFT studies" [Pharmaceutic. Sci. Adv. 4 (2026) 100108]Laiba Rashid, Jarin Tasnim, Md Mehedi Hasan, et al.
Pharmaceutical Science Advances|September 17, 2026
Corrigendum to "Immune mechanisms and novel therapies for idiopathic pulmonary fibrosis" [Pharmaceut. Sci. Adv. 2 (2024), 100030]Dongyang Gao, Wenli Gao, Zhiguang Zhai, et al.
Pageof 13